HealthLynked Corp. (OTCQB: HLYK), a healthcare technology company focused on AI-powered patient engagement, care coordination, and provider connectivity, has selected DRCARE247 as its telemedicine partner, according to a recent announcement. The partnership will integrate virtual care directly into the HealthLynked mobile application and website, enabling users to move from AI-powered health guidance to provider discovery, appointment scheduling, virtual consultations, and medical record management within a single platform.
The integration is expected to work alongside the company’s AI-powered patient assistant and, where clinically appropriate and permitted, may include prescription management as part of virtual consultations. HealthLynked expects to begin launching the integrated telemedicine platform in selected geographic regions over the next three months, followed by expansion into additional U.S. markets, subject to provider availability and applicable state requirements.
This move is significant for the healthcare industry as it reflects the growing convergence of artificial intelligence and telehealth to streamline patient care. By consolidating multiple functions into one platform, HealthLynked aims to enhance patient engagement and care coordination, potentially reducing costs and improving outcomes. The integration of virtual consultations with AI-driven insights could offer patients more personalized and timely care, while also addressing the fragmented nature of traditional healthcare delivery.
For investors, the partnership signals HealthLynked’s commitment to expanding its service offerings and capturing a larger share of the digital health market. The company’s cloud-based platform connects patients with providers for virtual or in-office appointments and consolidates medical records into one secure, accessible location. With AI-driven insights, integrated telehealth services, and intelligent patient engagement tools, HealthLynked empowers patients and providers to coordinate care more effectively while delivering savings on prescriptions and healthcare services.
The platform supports enterprise partnerships, offering scalable solutions to healthcare networks, employers, insurers, accountable care organizations, and digital health innovators. As the demand for telemedicine continues to rise, HealthLynked’s strategic move could position it as a key player in the evolving healthcare landscape.
For more details, the full press release is available at https://ibn.fm/HVq1Y. The latest news and updates relating to HLYK can be found in the company’s newsroom at https://ibn.fm/HLYLK.
BioMedWire, a specialized communications platform focused on the Biotechnology, Biomedical Sciences, and Life Sciences sectors, is one of 75+ brands within the Dynamic Brand Portfolio @ IBN. The platform delivers access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics, and diverse industries. It also provides article and editorial syndication to 5,000+ outlets, enhanced press release enhancement to ensure maximum impact, and social media distribution via IBN to millions of social media followers. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. For more information, please visit https://www.BioMedWire.com. Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer.
